EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families

Agne Cerkauskaite-Kerpauskiene, Milda Navickaite iD, Judy Savige, Gabija Mazur iD, Deimante Brazdziunaite iD, Karolis Azukaitis, Gerda Slazaite, Arvydas Laurinavicius iD, Marius Miglinas iD, Vija Vainutiene iD, Rasa Strupaite-Sileikiene, Ausrine Misevice und 2 weitere

International Journal of Molecular Sciences · 07.08.2025 · 26 (15) · 7639

DOI: 10.3390/ijms26157639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.08.2025. Verfasst von Agne Cerkauskaite-Kerpauskiene und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Collagen Type IV, Nephritis, Hereditary, Autoantigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in COL4A3 and COL4A4 cause autosomal dominant and recessive Alport syndrome, yet data on their distribution and clinical expression in different populations remain limited. This study investigated genotype–phenotype correlations and the distribution of COL4A3/COL4A4 variants in a Lithuanian Alport syndrome cohort. A total of 221 individuals from Lithuania were analyzed for COL4A3 and COL4A4 variants using either next-generation sequencing or Sanger sequencing in order to assess variant distribution and associated clinical features. Only individuals with pathogenic, likely pathogenic, or uncertain significance variants were included. Fifty-two individuals (38 index cases) with pathogenic, likely pathogenic, or variants of uncertain significance were identified, as follows: forty-eight were heterozygous, four had autosomal recessive, and four had digenic Alport syndrome. COL4A3 variants were found in 9.5% (21/221) and COL4A4 in 17.6% (39/221). Among the 28 identified variants, 18 were novel. Glycine substitutions (n = 8) were the most frequent and associated with worse kidney outcomes and increased hearing abnormalities. Hematuria was diagnosed significantly earlier than proteinuria (p = 0.05). Most individuals with autosomal dominant Alport syndrome had normal kidney function (eGFR > 90 mL/min/1.73 m2), while those with autosomal recessive Alport syndrome had more severe disease. Kidney failure occurred in 2/4 (50%) autosomal recessive Alport syndrome and 2/48 (4%) autosomal dominant Alport syndrome cases. A significant inverse correlation was found between eGFR and age in proteinuric individuals (r = –0.737; p = 0.013). This study expands knowledge of Alport syndrome in the Lithuanian population and contributes novel variant data to the global Alport syndrome genetic database.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IVNephritis, HereditaryAutoantigensHumansFemaleMaleAdultLithuaniaAdolescentMiddle AgedChildMutationYoung AdultGenetic Association StudiesPedigreePhenotypeChild, PreschoolGenetic VariationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

Alport syndromeCOL4A3COL4A4genotype–phenotype correlation

Substanzen

Collagen Type IVtype IV collagen alpha3 chainCOL4A4 protein, humanAutoantigens

Autor:innen und Institutionen

  • Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, LT-03101 Vilnius, Lithuania.
  • Vilnius University, Faculty of Medicine, LT-03101 Vilnius, Lithuania.
  • The University of Melbourne, Department of Medicine (MH and NH), Royal Melbourne Hospital Level CSB, Parkville, VIC 3050, Australia.
  • Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania.
  • Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, LT-03101 Vilnius, Lithuania.

ORCID-Profile: Milda Navickaite, Gabija Mazur, Deimante Brazdziunaite, Arvydas Laurinavicius, Marius Miglinas, Vija Vainutiene, Rimante Cerkauskiene

Zitieren

APA

Cerkauskaite-Kerpauskiene, A., Navickaite, M., Savige, J., Mazur, G., Brazdziunaite, D., Azukaitis, K., Slazaite, G., Laurinavicius, A., Miglinas, M., Vainutiene, V., Strupaite-Sileikiene, R., Misevice, A., Mickeviciene, V., & Cerkauskiene, R. (2025). Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families. International Journal of Molecular Sciences, 26(15), 7639. https://doi.org/10.3390/ijms26157639

Vancouver

Cerkauskaite-Kerpauskiene A, Navickaite M, Savige J, Mazur G, Brazdziunaite D, Azukaitis K, et al. Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families. International Journal of Molecular Sciences. 2025;26(15):7639. doi:10.3390/ijms26157639

BibTeX
@article{CerkauskaiteKerpauskiene2025,
  author = {Cerkauskaite-Kerpauskiene, Agne and Navickaite, Milda and Savige, Judy and Mazur, Gabija and Brazdziunaite, Deimante and Azukaitis, Karolis and Slazaite, Gerda and Laurinavicius, Arvydas and Miglinas, Marius and Vainutiene, Vija and Strupaite-Sileikiene, Rasa and Misevice, Ausrine and Mickeviciene, Vaiva and Cerkauskiene, Rimante},
  title = {Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7639},
  doi = {10.3390/ijms26157639}
}
Kostenlos starten →